Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 2,300 shares at $87.73 ($195K) on 2019-03-04, disclosed to the SEC on 2019-03-06.
Open-market sale of $195k BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.56 | 107 | $9K | 4.5% |
| 2 | $83.16 | 800 | $67K | 34.2% |
| 3 | $84.72 | 600 | $51K | 26.1% |
| 4 | $85.64 | 498 | $43K | 21.9% |
| 5 | $87.73 | 295 | $26K | 13.3% |
| Total | $84.66 avg | 2,300 |
| $195K |
| 100% |
| Filing → |
| BPMC | SELL | 2020-10-08 | $455K | — | Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |